September 10, 2015 / 2:05 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Envivio, Con-way, Krispy Kreme, Lululemon

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street opened slightly lower on Thursday as investors were wary of taking big bets ahead of the crucial U.S. Federal Reserve meeting next week. The Dow Jones industrial average was down 0.03 percent at 16,249.09, the S&P 500 was down 0.05 percent at 1,941.08 and the Nasdaq Composite was up 0.11 percent at 4,761.582.

** APPLE INC, $111.17, +0.93 pct

Apple unveiled a new TV set top box that responds to voice commands and fresh iPhones that sense the pressure of a finger tap.

** ENVIVIO INC, $4.05, +113.16 pct

The video processing software provider agrees to be acquired by Ericsson, the world's No.1 mobile network equipment maker, in a deal valued at $125 million.

** XPO LOGISTICS INC, $29.86, -12.15 pct

** CON-WAY INC, $47.33, +33.21 pct

XPO said it would buy trucking and logistics company Con-way for $3 billion, including debt, making it the second largest provider of less-than-truckload services in North America.

** KRISPY KREME DOUGHNUTS INC, $15.28, -13.82 pct

The doughnut chain cuts FY 2016 profit forecast, blaming softer-than-expected sales in its consumer packaged goods category and charges on its derivative business.

** PALO ALTO NETWORKS INC, $174.33, +5.55 pct

The cyber security company reported its strongest revenue growth in 10 quarters and forecast better-than-expected growth in the current quarter as governments and companies spend more to protect themselves from cyber attacks.

** SEAGATE TECHNOLOGY PLC, $48.61, -2.97 pct

The hard-disk maker said it plans to cut 1,050 jobs, or 2 percent of its workforce, as part of a restructuring plan.

** LULULEMON ATHLETICA INC, $58.1, -9.29 pct

Shares of the Canadian yogawear retailer fell as results showed margins had narrowed due to higher operating costs, even as the company modestly raised its full-year earnings and sales forecasts on Thursday.

** MEDICINOVA INC, $3.2099, +4.22 pct

The U.S. FDA grants fast-track status for the company's experimental treatment of idiopathic pulmonary fibrosis - a fatal disease characterized by scarring of lungs.

** LA JOLLA PHARMACEUTICAL CO, $39.01, -7.80 pct

The drug developer's offering of 2.5 million shares was priced at $38 per share, representing a discount of 10 percent to the stock's Wednesday's closing price.

** CYTORI THERAPEUTICS INC, $0.5139, +25.65 pct

The drug developer says its experimental drug provided prolonged improvement in scleroderma patients with impaired hand function, showed a 12-month follow-up study.

** APRICUS BIOSCIENCES INC, $1.82, +7.06 pct

The drug developer takes back U.S. development and marketing rights for its erectile dysfunction cream, Vitaros, from Allergan Plc for a $1 million upfront payment and milestone payment of $1.5 million. (Compiled by Subrat Patnaik in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below